Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (7,345) $ (19,005)
Less: Gain (loss) from discontinued operations, net of tax 8,644 (3,053)
Net loss from continuing operations (15,989) (15,952)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Realized loss on marketable debt securities 0 18
Depreciation and amortization 3,869 4,664
Amortization of debt discount 1,813 983
Impairment loss 1,263 0
Amortization on operating lease right-of-use assets 227 338
Loss on issuance of debt 480 0
Stock-based compensation expense 1,460 3,021
Loss from lease termination 1,357 0
Employee retention tax credit income (1,929) 0
Inventory reserve 0 (24)
Loss (gain) from disposal of fixed assets 868 (91)
Change in fair value of warrant liability 225 0
Change in fair value of derivative liability 618 0
Debt extinguishment loss 498 0
Changes in operating assets and liabilities:    
Accounts receivable (7) 4,824
Inventory 313 587
Prepaid expenses and other current assets (1,209) (688)
Deferred tax asset 0 (7,427)
Other assets 0 854
Accounts payable and accrued expenses 565 4,820
Accrued diagnostic services (5) (276)
Accrued advertising and other allowances 0 98
Deferred revenue (519) (907)
Deferred tax liability 0 0
Lease liabilities (151) (1,404)
Income tax payable (1,696) (1,004)
Other liabilities 238 (1,022)
Net cash used in operating activities - continuing operations (7,711) (8,588)
Net cash provided by (used in) operating activities - discontinued operations 597 (5,432)
Net cash used in operating activities (7,114) (14,020)
Cash flows from investing activities    
Proceeds from sales of marketable securities 0 3,374
Proceeds from sales of fixed assets 120 229
Capital expenditures 0 (866)
Net cash provided by investing activities - continuing operations 120 2,737
Net cash provided by (used in) investing activities - discontinued operations 800 (275)
Net cash provided by investing activities 920 2,462
Cash flows from financing activities    
Proceeds from issuance of note payable, net 2,914 8,334
Proceeds from issuance of note payable to related party, net 500 0
Proceeds from issuance of convertible notes payable 3,000 0
Proceeds from issuance of common shares, net 3,558 4,624
Repayment of note payable (4,016) (2,492)
Net cash provided by financing activities - continuing operations 5,956 10,466
Net cash used in financing activities - discontinued operations (35) (16)
Net cash provided by financing activities 5,921 10,450
Decrease in cash and cash equivalents (273) (1,108)
Cash and cash equivalents at the beginning of the period 678 1,609
Cash and cash equivalents at the end of the period 405 501
Supplemental disclosures:    
Cash paid for income taxes 1,094 860
Interest payments 1,161 2,126
Supplemental disclosure of non-cash investing and financing activities:    
Issuance of common stock as commitment fee for future financing 158 0
Issuance of liability classified warrants associated with notes payable 230 0
Net unrealized (gain) loss, investments in marketable debt securities 0 267
Deconsolidation of subsidiaries assets and liabilities (16,003) 0
Recognition investment in nonconsolidated subsidiaries $ 43,657 $ 0